A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy
A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy
Laboratory Investigation 97,
1245 (October 2017). doi:10.1038/labinvest.2017.40
Authors: Shubhashish Sarkar, Vsevolod L Popov, Malaney R O'Connell, Heather L Stevenson, Brian S Lee, Robert A Obeid, Gurinder K Luthra & Pomila Singh
Source: Laboratory Investigation - Category: Laboratory Medicine Authors: Shubhashish Sarkar Vsevolod L Popov Malaney R O'Connell Heather L Stevenson Brian S Lee Robert A Obeid Gurinder K Luthra Pomila Singh Source Type: research
More News: Cancer | Cancer & Oncology | Colon Cancer | Colonoscopy | Colorectal Cancer | Laboratory Medicine | Stem Cell Therapy | Stem Cells